Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The present study was aimed to evaluate a liposomal formulation of amiloride on experimental seizure models including the increasing current electroshock seizure threshold test (ICES), pentylenetetrazole (PTZ)-induced seizures and PTZ-induced status epilepticus in mice. Further, the effect of liposomal amiloride on serum K(+) levels was also investigated using flame photometry. We found an improved anticonvulsant action with liposome-entrapped amiloride as compared to free amiloride. Further, free amiloride showed an increase in serum K(+) levels, however the latter was unaffected with liposomal formulation treatment. These results, together with previously published data, suggest that as drug delivery vehicles, liposomes can enhance the effectiveness of drugs in the CNS without producing peripheral toxicity (hyperkalemia).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euroneuro.2006.05.003DOI Listing

Publication Analysis

Top Keywords

free amiloride
12
liposome-entrapped amiloride
8
amiloride free
8
liposomal formulation
8
serum levels
8
amiloride
7
comparative efficacy
4
efficacy liposome-entrapped
4
amiloride animal
4
animal models
4

Similar Publications

Background: Acute kidney injury (AKI) is a serious complication associated with envenomation, primarily due to direct nephrotoxicity. This study aimed to investigate the effects of the phospholipase A (RvPLA₂) fraction from venom on renal function and to assess whether pretreatment with ion channel blockers could mitigate these effects using an isolated perfused kidney (IPK) model.

Methods: Twenty IPKs were allocated into five groups (n = 4 each): (1) RvPLA₂ in calcium-deficient modified Krebs-Henseleit solution (MKHS), (2) RvPLA₂ in standard MKHS, (3) RvPLA₂ following pretreatment with verapamil (a voltage-gated Ca²⁺ channel blocker), (4) RvPLA₂ following pretreatment with amiloride (a Na⁺ channel blocker), and (5) RvPLA₂ following pretreatment with minoxidil (a KATP channel opener).

View Article and Find Full Text PDF

Lactic acidosis commonly impairs myocardial contractility in vertebrates, limiting cardiac performance under metabolic stress. However, the rheophilic Neotropical species matrinxã (Brycon amazonicus) appears to exhibit physiological adaptations that support cardiac resilience. In this study, ventricular muscle strips were exposed to extracellular lactic acidosis (LA, 22 mM lactic acid, pH 6.

View Article and Find Full Text PDF

Background: -Nasal Potential Difference (NPD) is an established diagnostic tool for CF. However, standardized values for very young patients are lacking.

Aim: - To evaluate the feasibility of performing NPD testing in young children.

View Article and Find Full Text PDF

Involvement of Cholinergic and Cyclooxygenase Pathways in the Diuretic Effects of Rosmarinic Acid.

Chem Biodivers

March 2025

Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, 88302-901 -, Itajaí, Santa Catarina, Brasil.

Rosmarinic acid (RA) is a natural antioxidant known for its diverse biological activities. Although its diuretic activity has been previously established, the mode of action remained unclear. To investigate this, we examined the diuretic activity of RA alone and in combination with hydrochlorothiazide (HCTZ), amiloride (AML), atropine (ATR), and indomethacin (INDO) to see if any of these drugs could interfere with RA's activity in an 8 hour acute diuresis animal model.

View Article and Find Full Text PDF

Evaluation of the translation of multiple cardiovascular regulatory mechanisms in the anesthetized dog.

J Pharmacol Toxicol Methods

March 2024

AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL 60064, United States of America.

The strategic and targeted use of an anesthetized canine cardiovascular model early in drug discovery enables a comprehensive cardiovascular and electrophysiological assessment of potential safety liabilities and guides compound selection prior to initiation of chronic toxicological studies. An ideal model would enable exposure-response relationships to guide safety margin calculations, have a low threshold to initiate, and have quick delivery of decision quality data. We have aimed to profile compounds with diverse mechanism of actions (MoAs) of "non-QT" cardiovascular drug effects and evaluate the ability of nonclinical in vivo cardiovascular models to detect clinically reported effects.

View Article and Find Full Text PDF